Why TACTIC?

Living longer doesn’t automatically equate to living better” “One-size-fit-all dosing can lead to high toxicity in some people that forces them to abandon the therapy that might benefit them.”
– Jill Feldman, lung cancer survivor and EGFR Resisters Founder

“Driving awareness, and availing clinicians and researchers of potential data resources is a critical step forward to improve the prevention and care of various treatment toxicities in cancer.”
– Sarah Greene, endometrial cancer survivor and health systems advisor

  • Advocate to support funding for national infrastructure, public access, global collaboration, clinical and implementation research to improve care for patients facing cancer treatment toxicities.
  • Engage with stakeholders in delivering better care for patients facing cancer cancer treatment toxicities in diverse populations and healthcare settings.
  • Identify the challenges and research opportunities both short-term and long-term in order to provide evidences to support better clinical decisions.
  • Lead or participate in clinical research and implementation research efforts that can lead to improved guidances, practices, and resources for cancer patients facing treatment toxicities.